{"id":989328,"date":"2026-08-04T10:38:14","date_gmt":"2026-08-04T14:38:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2026-08-04T10:38:14","modified_gmt":"2026-08-04T14:38:14","slug":"lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"Lucid Diagnostics to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">NEW YORK<\/span>, <span class=\"legendSpanClass\">Aug. 4, 2026<\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4744528-1&amp;h=1238369017&amp;u=https%3A%2F%2Fwww.luciddx.com%2F&amp;a=Lucid+Diagnostics+Inc.\" target=\"_blank\" rel=\"nofollow\"><b>Lucid Diagnostics Inc.<\/b><\/a>\u00a0(Nasdaq: LUCD)\u00a0(&#8220;Lucid&#8221; or the &#8220;Company&#8221;), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that management will participate in the following upcoming investor conferences:<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <img decoding=\"async\" src=\"https:\/\/mmx.prnewswire.com\/media\/MS1416381\/Lucid-TM-Logo.jpg?id=OA2822230\" title=\"Lucid Diagnostics Inc., markets the first and only commercial tools for widespread early detection of esophageal precancer and cancer \u2013 the EsoGuard\u00ae Esophageal DNA Test and EsoCheck\u00ae Esophageal Cell Collection Device.\" alt=\"Lucid Diagnostics Inc., markets the first and only commercial tools for widespread early detection of esophageal precancer and cancer \u2013 the EsoGuard\u00ae Esophageal DNA Test and EsoCheck\u00ae Esophageal Cell Collection Device.\" \/>\n        <\/p>\n<\/p><\/div>\n<ul type=\"disc\">\n<li>\n          <b>11<\/b><br \/>\n          <b><br \/>\n            <sup>th<\/sup><br \/>\n          <\/b><br \/>\n          <b> Annual Needham Virtual MedTech &amp; Diagnostics 1&#215;1 Conference <\/b><\/p>\n<ul type=\"circle\">\n<li>\n              <b>1&#215;1 Meetings<\/b>: August 10, 2026<\/li>\n<li>\n              <b>Location<\/b>: Virtual<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n          <b>Canaccord Genuity 46<\/b><br \/>\n          <b><br \/>\n            <sup>th<\/sup><br \/>\n          <\/b><br \/>\n          <b> Annual Growth Conference <\/b>\n        <\/li>\n<li style=\"list-style-type: none\">\n<ul type=\"circle\">\n<li>\n              <b>Fireside Chat<\/b>: August 11, 2026, at 11:30 AM ET<\/li>\n<li>\n              <b>Location<\/b>: Boston, MA<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>The live and archived webcast of the Canaccord Genuity fireside chat can be accessed by clicking <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4744528-1&amp;h=3850795554&amp;u=https%3A%2F%2Fevent.summitcast.com%2Fview%2FWuFmFdTcA9mVsUGHZJFU62%2Fguest_book%3Fsession_id%3DGxVhwEEbCyvi3znMmqeFdT&amp;a=here\" target=\"_blank\" rel=\"nofollow\">here<\/a>\u00a0or by visiting the <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4744528-1&amp;h=4245416162&amp;u=https%3A%2F%2Fir.luciddx.com%2F&amp;a=Investor+Relations+Section\" target=\"_blank\" rel=\"nofollow\">Investor Relations Section<\/a>\u00a0of the Lucid Diagnostics website.\u00a0\u00a0A replay of the webcast will be available on the website for 30 days following the conclusion of the live broadcast.<\/p>\n<p>\n        <b>About Lucid Diagnostics<br \/><\/b>Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid&#8217;s <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4744528-1&amp;h=3313472795&amp;u=http%3A%2F%2Fwww.esoguard.com%2F&amp;a=EsoGuard%C2%AE%C2%A0Esophageal+DNA+Test\" target=\"_blank\" rel=\"nofollow\">EsoGuard<sup>\u00ae<\/sup>\u00a0Esophageal DNA Test<\/a>, performed on samples collected in a brief, noninvasive office procedure with its <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4744528-1&amp;h=2702849297&amp;u=https%3A%2F%2Fwww.luciddx.com%2Fprecancer-detection%2Fesocheck&amp;a=EsoCheck%C2%AE%C2%A0Esophageal+Cell+Collection+Device\" target=\"_blank\" rel=\"nofollow\">EsoCheck<sup>\u00ae<\/sup>\u00a0Esophageal Cell Collection Device<\/a>, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4744528-1&amp;h=613434689&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4094243-1%26h%3D1289076475%26u%3Dhttp%253A%252F%252Fwww.luciddx.com%252F%26a%3Dwww.luciddx.com&amp;a=www.luciddx.com\" target=\"_blank\" rel=\"nofollow\">www.luciddx.com<\/a>\u00a0and for more information about its parent company PAVmed, please visit\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4744528-1&amp;h=3131951897&amp;u=https%3A%2F%2Fwww.pavmed.com&amp;a=www.pavmed.com\" target=\"_blank\" rel=\"nofollow\">www.pavmed.com<\/a>.<\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=NY17966&amp;sd=2026-08-04\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-302842362.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-302842362.html<\/a><\/p>\n<p>SOURCE Lucid Diagnostics<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY17966&amp;Transmission_Id=202608040830PR_NEWS_USPR_____NY17966&amp;DateId=20260804\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, Aug. 4, 2026 \/PRNewswire\/ &#8212; Lucid Diagnostics Inc.\u00a0(Nasdaq: LUCD)\u00a0(&#8220;Lucid&#8221; or the &#8220;Company&#8221;), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that management will participate in the following upcoming investor conferences: 11 th Annual Needham Virtual MedTech &amp; Diagnostics 1&#215;1 Conference 1&#215;1 Meetings: August 10, 2026 Location: Virtual Canaccord Genuity 46 th Annual Growth Conference Fireside Chat: August 11, 2026, at 11:30 AM ET Location: Boston, MA The live and archived webcast of the Canaccord Genuity fireside chat can be accessed by clicking here\u00a0or by visiting the Investor Relations Section\u00a0of the Lucid Diagnostics website.\u00a0\u00a0A replay of the webcast will be available on the website for 30 days following the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lucid Diagnostics to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-989328","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lucid Diagnostics to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lucid Diagnostics to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Aug. 4, 2026 \/PRNewswire\/ &#8212; Lucid Diagnostics Inc.\u00a0(Nasdaq: LUCD)\u00a0(&#8220;Lucid&#8221; or the &#8220;Company&#8221;), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that management will participate in the following upcoming investor conferences: 11 th Annual Needham Virtual MedTech &amp; Diagnostics 1&#215;1 Conference 1&#215;1 Meetings: August 10, 2026 Location: Virtual Canaccord Genuity 46 th Annual Growth Conference Fireside Chat: August 11, 2026, at 11:30 AM ET Location: Boston, MA The live and archived webcast of the Canaccord Genuity fireside chat can be accessed by clicking here\u00a0or by visiting the Investor Relations Section\u00a0of the Lucid Diagnostics website.\u00a0\u00a0A replay of the webcast will be available on the website for 30 days following the &hellip; Continue reading &quot;Lucid Diagnostics to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-04T14:38:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS1416381\/Lucid-TM-Logo.jpg?id=OA2822230\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lucid Diagnostics to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-08-04T14:38:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1416381\\\/Lucid-TM-Logo.jpg?id=OA2822230\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"Lucid Diagnostics to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1416381\\\/Lucid-TM-Logo.jpg?id=OA2822230\",\"datePublished\":\"2026-08-04T14:38:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1416381\\\/Lucid-TM-Logo.jpg?id=OA2822230\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1416381\\\/Lucid-TM-Logo.jpg?id=OA2822230\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lucid Diagnostics to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lucid Diagnostics to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Lucid Diagnostics to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"PR Newswire NEW YORK, Aug. 4, 2026 \/PRNewswire\/ &#8212; Lucid Diagnostics Inc.\u00a0(Nasdaq: LUCD)\u00a0(&#8220;Lucid&#8221; or the &#8220;Company&#8221;), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that management will participate in the following upcoming investor conferences: 11 th Annual Needham Virtual MedTech &amp; Diagnostics 1&#215;1 Conference 1&#215;1 Meetings: August 10, 2026 Location: Virtual Canaccord Genuity 46 th Annual Growth Conference Fireside Chat: August 11, 2026, at 11:30 AM ET Location: Boston, MA The live and archived webcast of the Canaccord Genuity fireside chat can be accessed by clicking here\u00a0or by visiting the Investor Relations Section\u00a0of the Lucid Diagnostics website.\u00a0\u00a0A replay of the webcast will be available on the website for 30 days following the &hellip; Continue reading \"Lucid Diagnostics to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-04T14:38:14+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS1416381\/Lucid-TM-Logo.jpg?id=OA2822230","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lucid Diagnostics to Participate in Upcoming Investor Conferences","datePublished":"2026-08-04T14:38:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1416381\/Lucid-TM-Logo.jpg?id=OA2822230","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/","name":"Lucid Diagnostics to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1416381\/Lucid-TM-Logo.jpg?id=OA2822230","datePublished":"2026-08-04T14:38:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS1416381\/Lucid-TM-Logo.jpg?id=OA2822230","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1416381\/Lucid-TM-Logo.jpg?id=OA2822230"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lucid-diagnostics-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lucid Diagnostics to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/989328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=989328"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/989328\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=989328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=989328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=989328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}